Keywords
Overweight
Comorbidity
How to Cite
Abstract
Introduction: Overnutrition generates a significant public health problem due to its healthcare and social costs. Objective: To identify patients with overnutrition and comorbidities who attend the nutrition clinic at the Bautista Medical Center from January 2023 to October 2024. Methodology: A retrospective, descriptive, cross-sectional observational study that included 93 patients, with a higher number of women 61.3% and men 39%. Results: The predominant age group was between 18 and 39 years (47.3%) with a mean of 43±19.8 years. Diagnosis based on body mass index (BMI) showed 60.2% obesity, 34.4% overweight, and 5.4% normal weight. The BMI by sex revealed a higher frequency of overweight or obesity. The percentage of overweight was higher in women than in men (25.8%; 8.6%), however, the degree of obesity was also higher in women than in men (31.2%; 29%). Abdominal circumference was increased in 83.3% of men, followed by 66.7% of women. Dyslipidemia was higher in 25.8% (n=24) of patients, hypertension in 21.5% (n=20), undoubtedly due to the percentage of dyslipidemia. Fatty liver disease was present in 11.8% (n=11) of patients, followed by diabetes in 10.8% (n=10) and prediabetes in 6.5% (n=6) Conclusion: The implication of overweight or obesity in the development of associated pathologies or comorbidities could be demonstrated, although the figures are worrying.
References
Ali, N., Mohanto, N. C., Nurunnabi, S. M., Haque, T., & Islam, F. (2022). Prevalence and risk factors of general and abdominal obesity and hypertension in rural and urban residents in Bangladesh: a cross-sectional study. BMC Public Health. 22(1): 1707. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-022-14087-8.
Bernal, R., Castro, G., Malé, R., Carmona, R., González, M., García, I., García-Juárez, N. Chávez-Tapia, C, Aguilar-Salinas, I., Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J.A. Velarde-Ruiz Velasc. (2019). Consenso mexicano de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México, 84(1), 69-99. https://www.sciencedirect.com/science/article/pii/S0375090618301794.
Caixas, A., Villaró, M., Arraiza, C., Montalvá, J. C., Lecube, A., Fernández-García, J. M, Corio R, Bellido D, Llisterri J & Tinahones F. (2020). SEEDO-SEMERGEN consensus document on continuous care of obesity between Primary Care and Specialist Hospital Units 2019. Documento de consenso de la Sociedad Española de Obesidad (SEEDO) y de la Sociedad Española de Médicos de Atención Primaria (SEMERGEN) sobre la continuidad asistencial en obesidad entre Atención Primaria y Unidades Especializadas Hospitalarias 2019. Medicina clínica, 155(6), 267.e1-267.e11. https://doi.org/10.1016/j.medcli.2019.10.014.
Collaboration NC; NCD Risk Factor Collaboration (NCD-RisC). (2017). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet; 390(10113): 2627-42. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32129-3/fulltext.
De Lorenzo, A., Gratteri, S., Gualtieri, P., Cammarano, A., Bertucci, P., Di Renzo, L. (2019). Why primary obesity is a disease? J Transl Med, 17(1), 169. https://doi.org/10.1186/s12967-019-1919-y
Ekpor, E., Akyirem, and S., Duodu, P. (2023). Prevalence and associated factors of overweight and obesity among persons with type 2 diabetes in Africa: a systematic review and meta-analysis. ANNALS OF MEDICINE, 55 (1), 696-713. https://doi.org/10.1080/07853890.2023.2182909
Fantin, F., Giani, A., Zoico, E., Rossi, A., Mazzali, G., Zamboni, M. (2019). Weight Loss and Hypertension in Obese Subjects. Nutrients, 11, 1667; https://doi.org/10.3390/nu11071667
Gómez Salas, G., Quesada Quesada, D., Monge Rojas, R. (2020). Perfil antropométrico y prevalencia de sobrepeso y obesidad en la población urbana de Costa Rica entre los 20 y 65 años agrupados por sexo: resultados del Estudio Latino Americano de Nutrición y Salud. Nutr Hosp,37(3),534-542. https://scielo.isciii.es/pdf/nh/v37n3/0212-1611-nh-37-3-534.pdf.
Harrison, S. A., Gawrieh, S., Roberts, K., Lisanti, C. J., Schwope, R. B., Cebe, K. M., Paradis, V., Bedossa, P., Aldridge Whitehead, J. M., Labourdette, A., Miette, V., Neubauer, S., Fournier, C., Paredes, A. H., & Alkhouri, N. (2021). Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. Journal of hepatology, 75(2), 284-291. https://doi.org/10.1016/j.jhep.2021.02.034.
Hulley, S.B., Cummings, S.M., Browner, W.S., Grady, D.G., Neuman, T.B. (2014). Diseño de investigaciones clínicas. 4° ed. Wolters Kluwer Health, Lippincott Williams & Wilkins.
Jastreboff, A.M., Kotz, C.M., Kahan, S., Kelly, A.S., Heymsfield, S.B. (2019). Obesity as a disease: the obesity society 2018 position statement. Obesity (Silver Spring),27(1),7-9. https://doi.org/10.1002/oby.22378.
Pineda, M.G., Benítez, A., Figueredo, R., Ayala, F. y Argüello, R. (2017). Frecuencia de hígado graso no alcohólico diagnosticado por ecografia abdominal en pacientes obesos. An. Fac. Cienc. Méd, 50(2), 35-50. http://dx.doi.org/10.18004/anales/2017.050(02)35-050.
OMS: Organización Mundial de la Salud. [Internet]. OMS; c2018 [Citado 1 de junio de 2018]. Enfermedades no transmisibles [aproximadamente 2 pantallas]. Available from: https://www.who.int/es/news-room/factsheets/detail/noncommunicable-diseases.
Mouton, A., Li, X., Hall, M., & Hall, J. (2020). Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation. Circ Res, 13, 126(6), 789-806. https://doi.org/10.1161/circresaha.119.312321.
Packer, M. (2019). Do Drugs That Ameliorate Epicardial Adipose Tissue Inflammation Have Concordant Benefits on Atrial Fibrillation and on Heart Failure with a Preserved Ejection Fraction? J Card Fail. https://doi.org/10.1016/j.cardfail.2019.09.002.
León-Samaniego, G., Vásquez, G., Encalada, G. y Bustamante, J. (2020). Prevalencia de obesidad y dislipidemias, y su relación con la hipertensión arterial en trabajadores universitarios en Ecuador. Salud y Bienestar Colectivo, 4(1), 33-43. https://sga.unemi.edu.ec/media/evidenciasiv/2022/03/14/articulo_202231415256.pdf.
Ministerio de Salud Pública y Bienestar Social. (2023). Dirección de Vigilancia Sanitaria. Segunda Encuesta Nacional sobre Factores de Riesgo de Enfermedades No transmisibles. Paraguay. https://www.ine.gov.py/resumen/223/segunda-encuesta-nacional-sobre-factores-de-riesgo-de-enfermedades-no-transmisibles.
Rohm, T.V., Meier, D.T., Olefsky, J.M., & Donath, M.Y. (2022). Inflammation in obesity, diabetes, and related disorders. Immunity, 55(1),31-55. https://doi.org/10.1016/j.immuni.2021.12.013.
Semlitsch, T., Stigler, F., Jeitler, K., Horvath, K., & Siebenhofe, A. (2019). Management of overweight and obesity in primary care A systematic overview of international evidence-based guidelines. Obesity Reviews, 20, 1218-1230. https://doi.org/10.1111/obr.12889.
World Obesity Federation. World Obesity Atlas 2024. London: World Obesity Federation, 2024. https://data.worldobesity.org/publications/?cat=22
Zapata, C., y Santiago, B. (2023). Perfil lipídico y su relación con las transaminasas en personas con sobrepeso u obesidad que acuden al Laboratorio Clínico Bio-Lab del cantón Pujilí. BS thesis. Universidad Técnica de Ambato/Facultad de Ciencias de la Salud/Carrera de Laboratorio Clínico. https://repositorio.uta.edu.ec/handle/123456789/37808.
This work is licensed under a Creative Commons Attribution 4.0 International License.